Praxis precision medicines to present on ulixacaltamide at the american academy of neurology 2024 annual meeting

Innovative design of ongoing phase 3 clinical program expected to set precedent for future clinical trials in essential tremor innovative design of ongoing phase 3 clinical program expected to set precedent for future clinical trials in essential tremor
PRAX Ratings Summary
PRAX Quant Ranking